№ lp_1_2_64873
File format: docx
Character count: 10257
File size: 136 KB
The document outlines the responsibilities and expectations of patients receiving therapy with drugs of dependence for pain and/or mental health management, as well as the conditions under which these medications are prescribed and monitored.
Year:
[insert year]
Region / City:
[insert region/city]
Topic:
Drugs of dependence, pain management, mental health treatment
Document Type:
Therapy Agreement
Organ / Institution:
[Insert practice name]
Author:
[insert author, if available]
Target Audience:
Patients receiving therapy for drugs of dependence
Period of Effectiveness:
[insert start date]
Approval Date:
[insert approval date]
Date of Revisions:
[insert revision date]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Note:
Year
Topic:
Tobacco dependence treatment
Document type:
Protocol
Organization / institution:
Local Stop Smoking Services (LSSS)
Target audience:
Healthcare professionals, practitioners in LSSS
Year:
2024
Region / city:
Australia
Theme:
Opioid dependence treatment, Pharmaceutical Benefits Scheme
Document type:
FAQ
Organization / institution:
Pharmaceutical Benefits Scheme
Author:
Pharmaceutical Benefits Scheme
Target audience:
Healthcare providers, prescribers, pharmacists
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A
Note:
Year
Topic:
Tobacco Dependence
Document type:
Clinical Guideline
Target audience:
All employees involved in providing care for patients who smoke
Year:
2019
Region / City:
Australia
Topic:
Opiate Dependence, Pharmaceutical Approval
Document Type:
Application for Pharmaceutical Listing
Organization / Institution:
PBAC, TGA
Author:
Indivior Pty Ltd
Target Audience:
Medical professionals, Pharmaceutical regulatory bodies
Effective Period:
From July 2019
Approval Date:
18 July 2019
Amendment Date:
17 July 2019
Year:
2020
Region / City:
United Kingdom
Topic:
Dependence Forming Medications
Document Type:
Prescribing Guide
Organisation:
Royal College of General Practitioners (RCGP)
Author:
Royal College of General Practitioners (RCGP)
Target Audience:
Healthcare professionals, particularly general practitioners
Period of validity:
Not specified
Approval Date:
15th October 2020
Date of Changes:
Not specified
Year:
2018
Region / city:
Greater Manchester
Theme:
Alcohol dependence treatment
Document type:
Protocol
Organization:
Greater Manchester Mental Health NHS Foundation Trust
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Until 22/08/2021
Approval date:
22/08/2018
Date of changes:
N/A
Year:
2023
Region / City:
Australia
Topic:
Opioid Dependence Treatment, Pharmaceutical Benefits Scheme
Document Type:
Government Report
Organization:
Australian Government Department of Health and Aged Care
Author:
Australian Government Department of Health and Aged Care
Target Audience:
Stakeholders, policymakers, healthcare providers, public
Effective Period:
2023-07-01 and onwards
Approval Date:
2023-03-01
Modification Date:
N/A
Interim Review Outcomes Date:
2023-03-01
Note:
Contextual Description
Year:
2023
Region / City:
London, United Kingdom
Topic:
Alcohol dependence, Alzheimer’s disease, neuroinflammation, cognitive impairment
Document type:
Research article
Organization / Institution:
Imperial College London, University of Edinburgh
Author:
Dr. Ashwin Venkataraman, Dr. Nicola Kalk, Dr. Gavin Sewell, Professor Craig W Ritchie, Professor Anne Lingford-Hughes
Target audience:
Researchers, clinicians, and academics in the field of neuroscience, psychiatry, and dementia
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Date:
April 2021
Geographic scope:
Australian Capital Territory; New South Wales; Queensland; Western Australia; South Australia; Tasmania; Northern Territory; Victoria
Country:
Australia
Subject:
Opioid dependence treatment programs
Document type:
Interjurisdictional summary report
Source of information:
Jurisdictional input responses and publicly available sources (NT)
Focus:
Funding arrangements, patient fees, prescriber requirements, pharmacy participation, correctional facility access
Medications referenced:
Long acting injectable buprenorphine (LAIB); buprenorphine; buprenorphine/naloxone; depot buprenorphine (BPN)
Related initiatives:
Opioid Treatment Program Strategic Action Plan (NSW); SafeScript implementation (VIC)
Timeframe referenced:
2020–21 (budget figures)
Year:
1989
Region / City:
Bali, Indonesia
Subject:
Plant pathology, rice tungro disease
Document Type:
Research article
Institution:
Food Crop Protection Center VII; Directorate of Crop Protection, Indonesia
Authors:
N. S. Astika, N. Suwela, G. N. Aryawan, Y. Suzuki
Target Audience:
Plant pathologists, agronomists, crop protection specialists
Research Period:
Late 1989, dry season
Variety Studied:
Krueng Aceh, IR36, IR64
Observation Duration:
5 weeks
Publication:
International Rice Research Newsletter, 1992
Volume / Issue:
17 (3)
Pages:
19-20
Year:
2020
Region / City:
Kolkata, West Bengal
Subject:
Alcohol dependence, de-addiction, psychiatric study
Document Type:
Research Study
Institution:
Institute of Psychiatry - COE, Kolkata
Authors:
Atasi Rani Mandal, Gita Purkait, Chandrima Maity
Target Audience:
Medical and psychiatric professionals, researchers in alcohol dependence
Duration of Study:
December 2019 to February 2020
Date of Approval:
Not specified
Date of Modifications:
Not specified
Keywords:
Alcohol, Dependency Level, Influencing Factors, Alcoholic Person, De-addiction, Alcoholism
Methodology:
Descriptive Survey, Convenience Sampling, Standardized Tools
Sample Size:
100
Sampling Method:
Non-probability Convenience Sampling
Tool Used:
AUDIT, SOCRATES Rating Scale, Structured Checklists
Content Validity:
95-100% Agreement from Experts
Context:
This research identifies the level of alcohol dependency, influencing factors, challenges faced by individuals with alcohol dependence, and their attitudes towards de-addiction through a study conducted in a psychiatric hospital in Kolkata.
Year:
1989
Jurisdiction:
Australian Capital Territory
Subject:
Controlled substances and drug offences
Document type:
Legislation
Authority:
Australian Capital Territory Legislative Assembly
Author:
Parliamentary Counsel’s Office
Effective period:
14 May 2020 – 19 February 2021
Amendments:
Amendments under Legislation Act 2001, part 11.3 (Editorial changes)
Penalty units:
$160 for individuals, $810 for corporations
Commencement:
As specified in the Act and subsequent amendments
Modifications:
Current modifications indicated with symbol M in text
Uncommenced provisions:
Indicated with symbol U in text
Structure:
Includes Preliminary, Interpretation, Offences, Enforcement, Miscellaneous, Dictionary, Endnotes
Quantifying Firewood Extraction in Lake Malawi National Park: Local Dependence and Policy Challenges
Year:
2024
Region / Location:
Lake Malawi National Park, Malawi
Topic:
Firewood extraction and community dependence
Document type:
Research article
Institution:
Ryukoku University; University of Malawi; Tottori University
Authors:
Tamano Hayashi, James Banda, Patrick Chinguwo, Marlene Chikuni, Yasuko Kusakari, Nicholas Mantis, John Matewere, Placid Mpeketula, Shigeru Yanaka
Target audience:
Researchers, conservation policymakers, local resource managers
Study period:
1993–1994 (historical comparison) and 2024 (current survey)
Methods:
Household surveys, direct measurements of firewood collection
Key findings:
Annual collection of 11,976.34 megagrams of firewood, 88% household use, 77% self-gathered
Drivers of extraction:
Household size, reliance on biomass, lack of off-park alternatives
Policy implications:
Need for tree planting, agroforestry, improved cookstoves, alternative livelihoods
Keywords:
firewood, protected area, Lake Malawi National Park, community-based resource management, Sub-Saharan Africa
Year:
2023
Region / city:
Not specified
Topic:
Cathodoluminescence properties of SiO2:Pr³+ and ZnO.SiO2:Pr³+ nanophosphors
Document Type:
Research Paper
Organization:
Not specified
Author:
Not specified
Target Audience:
Researchers in material science and luminescence studies
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Keywords:
ZnO nanoparticles, SiO2:Pr³+ nanophosphors, Cathodoluminescence, Sol-gel method, X-ray diffraction, SEM, Optical absorption, Emission properties, FED technology
Context:
This document presents an experimental study on the cathodoluminescence properties of SiO₂:Pr³⁺ and ZnO.SiO₂:Pr³⁺ nanophosphors, including their synthesis, characterization, and performance under varying experimental conditions.
Year:
2023
Note:
Region / City
Subject:
Billing Requirements for Drugs and Biologicals with Discarded Amounts
Document Type:
Policy
Organization / Institution:
SummaCare, Apex Summa Health Management Company, Summa Insurance Company
Target Audience:
Providers, Healthcare Administrators, Claims Department
Effective Period:
From 01/01/2017
Approval Date:
08/15/2023
Review Date:
Every 2 years or as necessary
Compliance Statement:
All members of the workforce are responsible for compliance with this policy.
Monitoring and Auditing:
Claims Department
Documentation Retention:
Minimum of 10 years
Purpose:
To outline the billing requirements for drugs and biologicals with unused and discarded amounts from single-dose containers or single-use packages.
Description:
Guidelines on proper billing procedures for drugs and biologicals, including the use of JW and JZ modifiers for discarded drug amounts or no wastage in single-dose vials, applicable to providers and insurers.
Year:
2025
Region / City:
Not specified
Theme:
Healthcare, Drug Coverage
Document Type:
Informational Flyer
Organization / Institution:
Wellcare
Author:
Not specified
Target Audience:
Healthcare providers, insurance plan members
Period of Validity:
Not specified
Approval Date:
07/24/2024
Date of Changes:
Not specified
Year:
2021
Region / City:
Australia
Theme:
Mental health, Alcohol and Other Drugs
Document Type:
Unit of competency
Organization / Institution:
Australian Skills Quality Authority (ASQA)
Author:
Not specified
Target Audience:
People working in community services, mental health and alcohol and other drug sectors
Period of validity:
Not specified
Approval Date:
Not specified
Date of modifications:
Release 2, Modification History: Release 2
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Unit code:
CHCAOD007
Release:
2
Type:
Competency unit
Sector:
Health and community services
Target group:
Workers supporting people with alcohol and other drug challenges
Application:
Relapse prevention and management strategies
Legislation and standards:
Commonwealth and State/Territory legislation, Australian/New Zealand standards, industry codes of practice
Skills:
Relapse prevention planning, risk assessment, harm minimisation, communication, crisis management
Assessment:
Workplace demonstration or simulated environment, treatment plans, risk assessment tools
Knowledge:
Legal and ethical considerations, AOD effects and responses, relapse triggers, support strategies, therapy options, environmental and individual risk factors